SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001437749-22-021412
Filing Date
2022-08-26
Accepted
2022-08-26 18:06:18
Documents
2
Period of Report
2022-05-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 rdgdoc.html 3  
1 FORM 3 rdgdoc.xml 3 1412
2 poa_rjaeger.htm EX-24 7639
  Complete submission text file 0001437749-22-021412.txt   10738
Mailing Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902
Business Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Issuer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902
Business Address
JAEGER RAVEN (Reporting) CIK: 0001944263 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37942 | Film No.: 221206540